학술논문

The effects of single- and multiple-dose administration of bococizumab (RN316/PF-04950615), a humanized IgG2Δa monoclonal antibody binding proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects treated with and without atorvastatin: Results from four phase I studies
Document Type
Article
Source
In: Cardiovascular Therapeutics. (Cardiovascular Therapeutics, February 2018, 36(1))
Subject
Language
English
ISSN
17555922
17555914